GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Estrella Immunopharma Inc (NAS:ESLAW) » Definitions » Change In Prepaid Assets

Estrella Immunopharma (Estrella Immunopharma) Change In Prepaid Assets : $-3.51 Mil (TTM As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Estrella Immunopharma Change In Prepaid Assets?

Estrella Immunopharma's Change In Prepaid Assets for the quarter that ended in Mar. 2024 was $-3.51 Mil. It means Estrella Immunopharma's Prepaid Assets declined by $3.51 Mil from Dec. 2023 to Mar. 2024 .

Estrella Immunopharma's Change In Prepaid Assets for the fiscal year that ended in Jun. 2021 was $0.00 Mil. It means Estrella Immunopharma's Prepaid Assets stayed the same from . 20 to Jun. 2021 .


Estrella Immunopharma Change In Prepaid Assets Historical Data

The historical data trend for Estrella Immunopharma's Change In Prepaid Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Estrella Immunopharma Change In Prepaid Assets Chart

Estrella Immunopharma Annual Data
Trend Jun21
Change In Prepaid Assets
-

Estrella Immunopharma Quarterly Data
Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Sep23 Dec23 Mar24
Change In Prepaid Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only - -0.05 - - -3.51

Estrella Immunopharma Change In Prepaid Assets Calculation

Change In Prepaid Assets is any increase or decrease between periods of the prepaid assets.

Change In Prepaid Assets for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-3.51 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Estrella Immunopharma Change In Prepaid Assets Related Terms

Thank you for viewing the detailed overview of Estrella Immunopharma's Change In Prepaid Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Estrella Immunopharma (Estrella Immunopharma) Business Description

Traded in Other Exchanges
Address
5858 Horton Street, Suite 170, Emeryville, CA, USA, 94608
Estrella Immunopharma Inc is a preclinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer.

Estrella Immunopharma (Estrella Immunopharma) Headlines

No Headlines